Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark

More Jobs >>

Events

Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami

More Events >>

Juvaris BioTherapeutics News

Most Popular Juvaris BioTherapeutics Story

Juvaris completes $25M close of series B

September 17, 2009 — 8:56am ET | By Calisha Myers

Adjuvant vaccines developer Juvaris BioTherapeutics has completed the first close of a Series B round. The Burlingame, CA-based company says it will use the capital to advance its technology platform Read more...

Juvaris BioTherapeutics Press Releases

Juvaris BioTherapeutics Announces First Close on $25 Million Series B Financing
Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen Discovery, Inc.
Juvaris BioTherapeutics' Vaccine Adjuvant, JVRS-100, Generates Superior T-Cell Mediated Immune Responses to Influenza
Juvaris BioTherapeutics Announces Positive Data from Clinical Trial of JVRS-100 Adjuvanted Flu Vaccine

Latest Headlines

Juvaris completes $25M close of series B
September 17, 2009

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK